• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Heart Journal
      • 3.4, 2.3
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Heart Journal
      • 3.4, 2.3
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      A DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL TRIAL OF VITAMIN C TREATMENT IN MIDDLE AGED PATIENTS (35-50 YEARS OLD) WITH MILD PRIMARY HYPERTENSION

      (ندگان)پدیدآور
      FOROUD, AFOROUD, AFSAR
      Thumbnail
      نوع مدرک
      Text
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Objective: An evaluation of the effect of vitamin C on blood pressure is very important because hypertension is a major risk factor for cardiovascular, cerebral and renal diseases.We studied the effect of vitamin C on the blood pressure of patients between 35-50 years old with mild primary hypertension in Kerman.Methods: We conducted a prospective one-year double-blind, placebo controlled parallel trial on 42 middle aged patients with mild primary hypertension at the hypertension clinic in Kerman University of Medical Sciences. Following a 2-week run-in phase, two age and sex matched groups of untreated hypertensive subjects received 8 weeks oral treatment with either vitamin C, 250 mg twice daily (n=21; 8 M/13F, mean age 42.7±5.3 years) or placebo one tablet twice daily (n=21; 10 M/IIF, mean age 42.7± 5.9 years). Blood pressure was measured in the sitting position on three occasions during the run-in phase, and again at 1, 2, 4 and 8 weeks after commencing treatment. Venous blood samples for the measurement of plasma ascorbic acid were measured at baseline and at 1, 2, 4, 8 weeks after treatment.Results: Plasma ascorbic acid level in vitamin C group significantly changed from 8.8±3 umol/l at baseline to 32.3±12 umolll at 8 weeks, but in placebo-treated group, it changed from 13.8±6 umolll at baseline to 9.01±4.1 umolll at 8 weeks during the study period.A more significant fall in mean blood pressure was observed in the vitamin C group than the placebo-treated group such that the mean systolic blood pressure decreased from 153.1± 5 to 144±5.3 mmHg in vitamin C group and from 154.1±4.9 to 149±4.9mmHg in the placebo group. The mean diastolic blood pressure decreased from 95.711.4 to 91.4±1.7 mmHg in the vitamin C group and from 96.2±1.6 to 94.0±1.6 mmHg in the other group.At 8 weeks, the significant difference in the reduction of systolic blood pressure (pConclusion: Vitamin C intake has a useful effect on lowering blood pressure.
      کلید واژگان
      systolic blood pressure
      DIASTOLIC BLOOD PRESSURE VITAMIN C
      Antioxidant

      شماره نشریه
      23
      تاریخ نشر
      2002-09-01
      1381-06-10
      ناشر
      Iranian Heart Association
      سازمان پدید آورنده
      SHAFA HOSPITAL, KERMAN UNIVERSITY OF MEDICAL SCIENCE, KERMAN IRAN

      URI
      http://journal.iha.org.ir/article_83520.html
      https://iranjournals.nlai.ir/handle/123456789/42874

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب